Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
03/2007
03/29/2007US20070072230 tubulin; inhibitor of cell proliferation; for drug screening
03/29/2007US20070072228 ERCC2 polymorphisms
03/29/2007US20070072218 A polynucleotide encoding a polypeptide having the amino acid sequence of SEQ ID NO:1, sequence operably linked to a heterologous promoter selected from hsp68, SV40, CMV, GAL4UAS, HSV and beta -actin; anticarcinogenic agents
03/29/2007US20070072217 XAF genes and polypeptides: methods and reagents for modulating apoptosis
03/29/2007US20070072206 nucleotide sequences used for genetic replication of chaperone protein targets, to improve the representation of diverse sequences in chaperone protein product libraries derived from complex templates
03/29/2007US20070072202 toll-like receptors; lipoproteins
03/29/2007US20070072199 Covalent methods for immobilization of thiolated biomolecules on siliceous and metallic surfaces
03/29/2007US20070072198 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
03/29/2007US20070072188 Methods for detection of mycobacterium tuberculosis
03/29/2007US20070072186 Methods and agents for screening for compounds capable of modulating her2 expression
03/29/2007US20070072185 Carbohydrate-binding modules of a new family
03/29/2007US20070072183 Topoisomerase hybrids and methods of use
03/29/2007US20070072182 Methods for amplification of nucleic acid sequences using staggered ligation
03/29/2007US20070072180 Using presence of polymorphism in allelic profile of nucleotide-binding oligomerization domain containing 2 (NOD2) gene as diagnostic indicatory of inflammatory disorders
03/29/2007US20070072177 Rabies virus G protein specific immunoglobulin for use in prevention and treatment of viral infections
03/29/2007US20070072176 Novel peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus
03/29/2007US20070071827 Polypeptides and Polynucleotides for Enhancing Immune Reactivity to HER-2 Protein
03/29/2007US20070071774 Protein D - an IgD-binding protein of Haemophilus influenzae
03/29/2007US20070071770 Recombinant MVA virus, and the use thereof
03/29/2007US20070071769 Recombinant MVA virus, and the use thereof
03/29/2007US20070071767 Polypeptides used for induction of cytotoxic T lymphocytes or activation of human leukocyte antigens (HLA), administered as anticarcinogenic vaccines; immunology
03/29/2007US20070071759 Antibody-immune cell ligand fusion protein for cancer therapy
03/29/2007US20070071755 Novel nucleolar GTPases and method for controlling proliferation of cells
03/29/2007US20070071752 Sphingosine kinase enzyme
03/29/2007US20070071751 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
03/29/2007US20070071750 Comprises heavy and light chain; treating envenomation by administering to neutralize in vivo effect
03/29/2007US20070071744 Agents which bind to epitopes of glycoprotein VI
03/29/2007US20070071743 Novel human cell surface protein with immunoglobulin folds, BGS-19
03/29/2007US20070071741 OCL-2A3 compositions and uses thereof
03/29/2007US20070071724 Methods for increasing learning and memory in amyloid-beta-related neurodegenerative disorders by increasing Uch-L1 activity and methods for identifying enhancers of Uch-L1 activity
03/29/2007US20070071719 Compositions and methods for regulation of tumor necrosis factor-alpha
03/29/2007US20070071714 Stem cell factor
03/29/2007US20070071675 Engineered multivalent and multispecific binding proteins; treatment of acute and chronic inflammatory, cancer
03/29/2007US20070071674 Polynucleotides encoding novel isoforms of IGSF9
03/29/2007DE102005046490A1 New nucleic acid molecule comprising promoter, a transcriptable nucleic acid sequence, a first and second nucleic acid sequence for producing modified RNA with transcriptional stability and translational efficiency
03/29/2007DE10006591B4 Verfahren zur Aufreinigung von Nukleinsäuren A method for purifying nucleic acids
03/29/2007CA2812343A1 Methods for genetic control of insect infestations in plants and compositions thereof
03/29/2007CA2623772A1 Modulation of glucocorticoid receptor expression
03/29/2007CA2623425A1 Methods for diagnosing pancreatic cancer
03/29/2007CA2623424A1 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics
03/29/2007CA2623181A1 Reagents, methods and kits for selection of anti-fungal therapy for candida species fung i
03/29/2007CA2622712A1 Compositions and methods for purifying nucleic acids
03/29/2007CA2622422A1 Methods for screening for compounds that modulate insulin promoter activity
03/28/2007EP1767632A2 A method for local administration of synthetic double-stranded oligonucleotides targeting a VEGF receptor
03/28/2007EP1767621A1 Method of purifying environmental dna and method of efficiently screening protein-encoding gene from environmental dna
03/28/2007EP1766388A2 Stable isotope labeled polypeptide standards for protein quantitation
03/28/2007EP1766093A2 Antibodies against clostridium difficile toxins and uses thereof
03/28/2007EP1766091A2 Biomarkers for monitoring inhibition of impdh pathway
03/28/2007EP1766080A2 Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in lung cancer cells
03/28/2007EP1766079A2 Diagnosing or predicting the course of breast cancer
03/28/2007EP1766075A2 Method for nucleic acid analysis
03/28/2007EP1766073A1 Enhancing protein expression
03/28/2007EP1766072A2 Hybridization of pna probes in alcohol solutions
03/28/2007EP1766071A2 Double strand compositions comprising differentially modified strands for use in gene modulation
03/28/2007EP1766068A2 Egfr mutations
03/28/2007EP1766053A2 Rna-containing microvesicles and methods therefor
03/28/2007EP1766052A1 Chimeric gapped oligomeric compositions
03/28/2007EP1766050A1 Assay system using labeled oligonucleotides
03/28/2007EP1766021A1 Polynucleotides for the detection of escherichia coli 157:h7 and escherichia coli 0157:nm verotoxin producers
03/28/2007EP1766020A1 Polynucleotides for the detection of staphylococcus aureus
03/28/2007EP1766015A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans
03/28/2007EP1766010A1 Antisense oligonucleotides for inducing exon skipping and methods of use thereof
03/28/2007EP1765996A2 Mammalian endonucleases and methods of use
03/28/2007EP1765994A2 Reconstituted histone methyltransferase complex and methods of identifying modulators thereof
03/28/2007EP1765993A2 Truncated st6galnaci polypeptides and nucleic acids
03/28/2007EP1765856A2 Rna-dependent dna polymerase from geobacillus stearothermophilus
03/28/2007EP1765853A2 O-linked glycosylation of peptides
03/28/2007EP1765847A2 Nuclease resistant double-stranded ribonucleic acid
03/28/2007EP1765846A2 Aav vector compositions and methods for enhanced expression of immunoglobulins using the same
03/28/2007EP1765845A1 Stable cyanine dye phosphoramidites
03/28/2007EP1765418A2 Method for enhancing production of isoprenoid compounds
03/28/2007EP1765417A2 Immunostimulatory oligonucleotide multimers
03/28/2007EP1765416A2 Double strand compositions comprising differentially modified strands for use in gene modulation
03/28/2007EP1765415A2 Oligomeric compounds that facilitate risc loading
03/28/2007EP1765386A2 Truncated hepatitis c virus ns5 domain and fusion proteins comprising same
03/28/2007EP1765316A2 Methods and compositions for modulating bax-ku70-mediated apoptosis
03/28/2007EP1765074A2 POSITIONALLY MODIFIED siRNA CONSTRUCTS
03/28/2007EP1718743A4 Anti-freeze protein enhanced nucleic acid amplification
03/28/2007EP1687445A4 Polymeric nucleic acid hybridization probes
03/28/2007EP1687429A4 Promoters functional in plant plastids
03/28/2007EP1685149A4 Primers, methods and kits for detecting killer-cell immunoglobulin-like receptor alleles
03/28/2007EP1309604B1 Phage-dependent superproduction of biologically active protein and peptides
03/28/2007CN1938428A Plasmid system for multigene expression
03/28/2007CN1938329A Labelling reagents, methods for the synthesis of such reagents and methods for the detection of biological molecules
03/28/2007CN1938328A Nucleotide derivative and DNA microarray
03/28/2007CN1936012A Method for coustructing shRNA expression carrier for inhibiting N-acetylglucosamine transferase V and its use
03/28/2007CN1936000A Fennero penaeus chinensis antibacterial protein gene and recombinant expression and use
03/28/2007CN1935829A Nucleic acid hydrolysis cutting agent based on cucurbituril
03/28/2007CN1307308C Nucleotide specific for Escherichia coli 085-type O-antigen
03/28/2007CN1307307C Nucleotide specific for Shigella bogdii B14-type O-antigen
03/28/2007CN1307306C Nucleotide specific for Escherichia coli 011-type O-antigen
03/28/2007CN1307305C Nucleotide sequence specific for O-antigen of E.coli 076 type
03/28/2007CN1307196C Modified CpG oligodeoxynucleotide with improved immunoregulatory function
03/28/2007CN1307195C High level expression of proteins
03/28/2007CN1306956C Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies
03/27/2007US7196190 An expression cassette comprising a specific isolated polynucleotide comprising a transcription control element and a reporter sequence, operably linked to transcription control unit encodes a light generating protein
03/27/2007US7196189 Comprises modified lovastatin regulatory proteins for use in treatment of hypercholesterolemia
03/27/2007US7196188 Methods and compositions for screening of human borna disease virus
03/27/2007US7196187 Method for producing antibody fragments
03/27/2007US7196186 Plasmid comprising nucleotide sequences coding antigenic proteins for use in prevention and treatment of infectious and neoplastic diseases; gene therapy